Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 52, 2018 - Issue 5-6
Journal homepage
89
Views
0
CrossRef citations to date
0
Altmetric
Articles

The association of atrophy in baseline prostate biopsy and lower prostate cancer grade in radical prostatectomy specimens

D. M. O. FreitasDepartment of Urology, Nossa Senhora da Conceição Hospital, Porto Alegre, Brazil;
,
G. L. AndrioleDivision of Urologic Surgery, Washington University School of Medicine, St. Louis, M.O., U.S.A;
,
R. Castro-SantamariaGlaxoSmithKline Inc., Global R&D, King of Prussia, Pennsylvania, P.A., U.S.A;
,
S. J. FreedlandCenter for Integrated Research on Cancer and Lifestyle, Samuel Oschin Comprehensive Cancer Institute and the Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, C.A., U.S.A; ;Durham V.A. Medical Center, Durham, N.C., U.S.A.;
&
D. M. MoreiraDepartment of Urology, University of Illinois at Chicago, Chicago, I.L., U.S.A.Correspondence[email protected]
Pages 328-332 | Received 18 Jul 2018, Accepted 18 Nov 2018, Published online: 14 Feb 2019

References

  • De Marzo AM, Platz EA, Epstein JI, et al. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006; 30:1281.
  • Billis A. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol. 1998; 11:47–54.
  • Prando A, Billis A. Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies. Abdom Imaging. 2009; 34:271–275.
  • Sánchez-Chapado M, Olmedilla G, Cabeza M, et al. Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: an autopsy study. Prostate. 2003; 54:238–247.
  • Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003; 349:213–232.
  • Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010; 362:1192.
  • Brasil AA, Favaro WJ, Cagnon VH, et al. Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer? Int Urol Nephrol. 2011; 43:397–403.
  • Tomas D, Kruslin B, Rogatsch H, et al. Different types of atrophy in the prostate with and without adenocarcinoma. Eur Urol. 2007; 51:98
  • Moreira DM, Bostwick DG, Andriole GL, et al. Baseline prostate atrophy is associated with reduced risk of prostate cancer in men undergoing repeat prostate biopsy. J Urol.2015; 194:1241–1246.
  • Jain S, Loblaw A, Vesprini D, et al. Gleason Upgrading with Time in a Large Prostate Cancer Active Surveillance Cohort. J Urol.2015; 194:79–84.
  • Pierorazio PM, Ross AE, Lin BM, et al. Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy. BJU Int.2012; 110:1122–1128.
  • Postma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005; 65:745–749.
  • Davidsson S, Fiorentino M, Andren O, et al. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev.2011; 20:2280–2287.
  • Freitas DM, Andriole GL, Castro-Santamaria R, et al. Extent of baseline prostate atrophy is associated with lower incidence of low- and high-grade prostate cancer on repeat biopsy. Urology. 2017;103:161–166.
  • Iczkowski KA, Torkko KC, Wilson RS, et al. Prostatic atrophy: its spatial proximity to carcinoma and intraepithelial neoplasia based on annotation of digital slides. Human Pathology.2014; 45:54–58.
  • Ferro M, Lucarelli G, Bruzzese D, et al. Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance. Oncotarget. 2017;8:18424–18434.
  • Servian P, Celma A, Planas J, et al. Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies. Prostate. 2016; 76:1501–1506.
  • Finn OJ. Cancer immunology. N Engl J Med. 2008;358:2704–2715. Jun 19;

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.